%0 Journal Article
%T Moderating Effects of Patient Characteristics on the Impact of Financial Incentives
%A Amanda Hodlofski
%A Andrea B. Troxel
%A AnneMarie G. Hirsch
%A Darra Finnerty
%A David A. Asch
%A Jack J. Huang
%A James B. Jones
%A Jingsan Zhu
%A Karen Hoffer
%A Kevin G. Volpp
%A Meredith B. Rosenthal
%A Thomas D. Sequist
%A Walter F. Stewart
%A Wenli Wang
%J Medical Care Research and Review
%@ 1552-6801
%D 2019
%R 10.1177/1077558717707313
%X While financial incentives to providers or patients are increasingly common as a quality improvement strategy, their impact on patient subgroups and health care disparities is unclear. To examine these patterns, we analyzed data from a randomized clinical trial of financial incentives to lower low-density lipoprotein (LDL) cholesterol levels in patients at risk for cardiovascular disease. Patients with higher baseline LDL experienced greater cholesterol reductions in the shared incentive arm (0.23 mg/dL per unit change in baseline LDL, 95% CI [£¿0.46, £¿0.00]) but were also less likely to have medication potency increases in the physician incentive arm (OR = 0.98, 95% CI [0.97, 0.996]). Uninsured patients and those of race other than Black or White were less likely to have potency increases in the shared incentive arm (OR = 0.15, 95% CI [0.03, 0.70] and OR = 0.09, 95% CI [0.01, 0.93], respectively). These findings suggest some differential response to incentives, particularly in the form of targeted medication changes
%K cardiovascular disease
%K health economics
%K patient engagement
%K physician behavior
%K randomized trials
%U https://journals.sagepub.com/doi/full/10.1177/1077558717707313